Skip to main content

Articles

Prostate Cancer
Oral Relugolix Equals Standard ADT, Slashes Cardiac Events in Patients with Advanced Prostate Cancer
Phoebe Starr
Read More
Lung Cancer, Oncology
Adjuvant Osimertinib a Practice-­Changing Treatment in Early-Stage NSCLC with EGFR Mutation
Wayne Kuznar
Read More
Practice Management
Clinical Decision Support Helps Compliance with Evidence-Based Pathways
Chase Doyle
Read More
Practice Management
Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma
Chase Doyle
Read More
Practice Management
Germline Alterations Analysis Has Actionable Value in Selecting Targetable Treatments for Patients with Advanced Cancer
Chase Doyle
Read More
Practice Management
The Value of Some Cancer Drugs Changes Substantially After Their Approval
Chase Doyle
Read More
Lung Cancer, Oncology
Durvalumab plus Chemotherapy New Standard of Care for Extensive-Stage Small-Cell Lung Cancer
Phoebe Starr
Read More
Lung Cancer, Oncology
Capmatinib Shows Activity in MET-Amplified Non–Small-Cell Lung Cancer
Wayne Kuznar
Read More
FDA Approvals
Tumor-Infiltrating Lymphocyte Therapy Induces Responses Across Wide Range of Patients with Advanced Melanoma
Wayne Kuznar
Read More
FDA Approvals
The WEE1 Inhibitor Adavosertib Displays Promising Clinical Activity in Uterine Serous Cancer
Wayne Kuznar
Read More
Page 33 of 244
Results 321 - 330 of 2440